NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neumous

Neumous

Private
South KoreaHealthcare & Life Scienceshttps://neumous.com/

Last Round

Series A

Jul 1, 2025

Total Funding Raised

$13.71M

Company Overview

Neumous is a medical device company that develops non-invasive therapeutic ultrasound technology to open the blood-brain barrier, enabling the delivery of drugs to treat brain diseases such as tumors and Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier openingBBB openingfocused ultrasoundtherapeutic ultrasoundbrain drug deliveryneurotechnologydrug delivery platformmedical devicesMedTechdrug repositioningAlzheimer's treatmentbrain tumor treatmentclinical trialspharmaceutical partnershipsreal-time monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neumous Comparables

Compare Neumous with similar companies based on industry and business-model similarity.

Neumous comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Neumous Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2025
GrantApr 1, 2024
GrantJun 1, 2023
GrantApr 1, 2023
SeedApr 1, 2023

Neumous Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    $7M round led by SL Investment.

  • Apr 1, 2024

    $1.2M grant from Ministry of Health and Welfare (South Korea)

Neumous Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neumous Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neumous's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Year Founded2022
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.